VISTAGEN THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.31 USD | -0.60% |
|
-4.89% | -35.60% |
| Jul. 01 | Vistagen Therapeutics, Inc.(NasdaqCM:VTGN) added to Russell 3000E Index | CI |
| Jul. 01 | Vistagen Therapeutics, Inc.(NasdaqCM:VTGN) added to Russell Microcap Index | CI |
Evolution of the average Target Price on Vistagen Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
535bdd.5dk-8sYVpusKs4H_iICcW2zyfZQzLdIl1H6hithqHwk.iaxQkKJ97qR_ns6Xu-j4AwDHE9dyGph6phns05wubDuvsHqTqHL2imTY6g~a941a10a745d037b94f0c76f317affbb
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.31
USD
Average target price
14
USD
Spread / Average Target
+322.96%
High Price Target
17
USD
Spread / Highest target
+413.60%
Low Price Target
12
USD
Spread / Lowest Target
+262.54%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Vistagen Therapeutics, Inc.
| Jefferies & Co. | |
| Stifel Nicolaus | |
| Maxim | |
| William Blair & Co. | |
| Baird |
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
- Stock Market
- Equities
- VTGN Stock
- Consensus Vistagen Therapeutics, Inc.
